发明名称 Specific binding proteins and uses thereof
摘要 The invention relates to specific binding members, particularly antibodies and active fragments thereof, which recognize an aberrant post-translationally modified, particularly an aberrant glycosylated form of the EGFR. The binding members, particularly antibodies and fragments thereof, of the invention do not bind to EGFR on normal cells in the absence of amplification of the wild- type gene and are capable of binding the de2-7 EGFR at an epitope which is distinct from the junctional peptids. Antibodies of this type are exemplified by the novel antibody 806 whose VH and VL sequences are illustrated as SEQ ID Nos: 2 and 4 and chimeric antibodies thereof as exemplified by ch806.
申请公布号 AU2002311919(B8) 申请公布日期 2007.03.22
申请号 AU20020311919 申请日期 2002.05.13
申请人 LUDWIG INSTITUTE FOR CANCER RESEARCH 发明人 ANDREW MARK SCOTT;WEBSTER K. CAVENEE;EDOUARD COLLINS NICE;PETER COLLINS;CHRISTOPH RENNER;GERD RITTER;LLOYD J. OLD;ANTHONY WILKS BURGESS;ACHIM JUNGBLUTH;ELISABETH STOCKERT;TERRANCE GRANT JOHNS;CON PANOUSIS;HUEI-JEN HUANG
分类号 G01N33/50;A61K39/00;A61K39/395;A61K45/00;A61K51/00;A61P35/00;C07K16/28;C07K16/32;C07K16/46;C07K19/00;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12P21/08;G01N33/15;G01N33/53;G01N33/566 主分类号 G01N33/50
代理机构 代理人
主权项
地址